UN's TB Plan Emphasizes Drug Development Collaboration, Universal Access To Treatment
IFPMA attends UN General Assembly high-level meeting on tuberculosis, commits to partner on prevention, support systems, and research.
You may also be interested in...
Promising Results In GSK Study Could Break Years Of TB Vaccine Deadlock
GlaxoSmithKline has published results from its latest Phase IIb trial of its investigational tuberculosis vaccine that show a subunit vaccine can reduce pulmonary TB, possibly leading the way for the first new vaccine for TB in over 90 years.
Call For India Compulsory Licenses For Last Resort TB Drugs
Public health campaigners in India and globally are pushing the government to allow Indian generic firms to make cheap copies of two new-generation, last resort antibiotics for drug-resistant tuberculosis through the use of patent-busting compulsory licenses.
Antimicrobial Resistance: Billions Needed To Encourage New Drugs
J&J exec says companies need $1bn to $2bn market entry reward; BARDA calls for system that assures companies get a sustained return on their investment.